Chevallard Daniel R.
LENZ Therapeutics, Inc. · Chief Financial Officer
Chevallard Daniel R. is listed in filings as Chief Financial Officer at LENZ Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 30, 2026, including purchase activity. Recent filings connect the profile to LENZ Therapeutics, Inc. (LENZ). The current snapshot covers public activity from Jan 13, 2025 to Mar 30, 2026. Reported amounts are shown as $1.9M to $49.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $45420 shares | BuyNov 7, 2025 | $22.71 | $4.88 | |
| $50k2.2k shares | BuyNov 7, 2025 | $22.76 | $4.88 |